1. Home
  2. SGMO vs SBI Comparison

SGMO vs SBI Comparison

Compare SGMO & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMO
  • SBI
  • Stock Information
  • Founded
  • SGMO 1995
  • SBI 1992
  • Country
  • SGMO United States
  • SBI United States
  • Employees
  • SGMO N/A
  • SBI N/A
  • Industry
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • SBI Finance/Investors Services
  • Sector
  • SGMO Health Care
  • SBI Finance
  • Exchange
  • SGMO Nasdaq
  • SBI Nasdaq
  • Market Cap
  • SGMO 122.8M
  • SBI 104.9M
  • IPO Year
  • SGMO 2000
  • SBI N/A
  • Fundamental
  • Price
  • SGMO $0.59
  • SBI $7.62
  • Analyst Decision
  • SGMO Buy
  • SBI
  • Analyst Count
  • SGMO 6
  • SBI 0
  • Target Price
  • SGMO $4.50
  • SBI N/A
  • AVG Volume (30 Days)
  • SGMO 5.2M
  • SBI 39.5K
  • Earning Date
  • SGMO 08-05-2025
  • SBI 01-01-0001
  • Dividend Yield
  • SGMO N/A
  • SBI 4.52%
  • EPS Growth
  • SGMO N/A
  • SBI N/A
  • EPS
  • SGMO N/A
  • SBI N/A
  • Revenue
  • SGMO $63,756,000.00
  • SBI N/A
  • Revenue This Year
  • SGMO $1.29
  • SBI N/A
  • Revenue Next Year
  • SGMO $1.60
  • SBI N/A
  • P/E Ratio
  • SGMO N/A
  • SBI N/A
  • Revenue Growth
  • SGMO 239.92
  • SBI N/A
  • 52 Week Low
  • SGMO $0.41
  • SBI $6.96
  • 52 Week High
  • SGMO $3.18
  • SBI $8.00
  • Technical
  • Relative Strength Index (RSI)
  • SGMO 60.91
  • SBI 51.25
  • Support Level
  • SGMO $0.50
  • SBI $7.61
  • Resistance Level
  • SGMO $0.65
  • SBI $7.71
  • Average True Range (ATR)
  • SGMO 0.04
  • SBI 0.04
  • MACD
  • SGMO 0.01
  • SBI -0.01
  • Stochastic Oscillator
  • SGMO 64.22
  • SBI 10.00

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About SBI Western Asset Intermediate Muni Fund Inc

Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.

Share on Social Networks: